Arsanis, Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
Related People
Fund Service Providers
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Arsanis, Inc.
CIK #0001501697
EDGAR Form CIK 2011 - 2026
10-K [0001501697]
10-Q [0001501697]
3 [0001501697]
4 [0001501697]
8-K [0001501697]
D [0001501697]
SC 13D [0001501697]
SC 13G [0001501697]
Form 13D/13G Filer Form 13D/13G Subject Filed
Saturn V Capital Management LP X4 Pharmaceuticals Inc [2026-02-17]
Morgan Stanley X4 Pharmaceuticals Inc [2026-02-12]
Nantahala Capital Management LLC X4 Pharmaceuticals Inc [2025-11-14]
FMR LLC X4 Pharmaceuticals Inc [2025-11-07]
Perceptive Advisors LLC X4 Pharmaceuticals Inc [2025-11-03]
Empery Asset Management LP X4 Pharmaceuticals Inc [2025-10-21]
Coastlands Capital LP X4 Pharmaceuticals Inc [2025-10-03]
Biotechnology Value Fund L P X4 Pharmaceuticals Inc [2025-08-20]
Deep Track Capital LP X4 Pharmaceuticals Inc [2025-08-19]
Coastlands Capital LP X4 Pharmaceuticals Inc [2025-08-18]
View All
Form 3/4/5 Subject 2011 - 2026
Gold Kelly
X4 Pharmaceuticals, Inc
Kirske David
Bridger Gary
Wyzga Michael S
de Craecker Francoise
Stewart Murray
Volpone John
Craig Adam R
Thoren Natasha Fay
View All
Terms | Privacy | Providers | Guide
tony@aum13f.com